发明名称 |
ORAL CONTROLLED RELEASE COMPOSITION CONTAINING LEVETIRACETAM |
摘要 |
<p>The present invention relates to an oral controlled release pharmaceutical composition in the form of a unit dosage form comprising: (a) a highly soluble high dose active ingredient consisting essentially of therapeutically effective amount of levetiracetam or a pharmaceutically acceptable derivative thereof, and (b) a rate controlling means comprising a rate-controlling agent and/or a coating selected from (i) a active ingredient permeable coating surrounding the unit dosage form, and (ii) an active ingredient impermeable coating covering one or more surfaces but not all the surfaces of the unit dosage form, wherein the composition is in the form of a compact tablet and the levetiracetam or a pharmaceutically acceptable derivative thereof is present in an amount ranging from about 55% to about 90% by weight of the tablet.</p> |
申请公布号 |
EP1909770(B1) |
申请公布日期 |
2013.03.20 |
申请号 |
EP20060780511 |
申请日期 |
2006.02.22 |
申请人 |
SUN PHARMACEUTICAL INDUSTRIES LIMITED |
发明人 |
ZALA, YASHORAJ, RUPSINH;DHARMADHIKARI, NITIN BHALACHANDRA |
分类号 |
A61K9/20;A61K31/4015 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|